Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-25-335484

Chief Medical Officer sold 5,600 shares at $13.15 ($73,623)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Karlin Daniel Chief Medical Officer 2025-12-26 Sale 10b5-1 −5,600 $13.15 $73,623 425,025 D: show line 1 in the form
Open-market sales · 5,600 sh · avg $13.15 · $73,623
Loading xslF345X05/ownership.xml…